GRI Bio, Inc. (GRI)
2.30
-0.11
(-4.56%)
USD |
NASDAQ |
Apr 24, 16:00
2.28
-0.02
(-0.87%)
After-Hours: 20:00
GRI Bio EPS Diluted (Quarterly) : -5.343 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | -1.359 |
| Akari Therapeutics Plc | 0.00 |
| Moleculin Biotech, Inc. | 4.829 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.659M |
| Total Expenses (Quarterly) | 2.659M |
| Enterprise Value | -4.676M |
| Earnings Yield | -3.64K% |
| Normalized Earnings Yield | -3640.80 |